Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_assertion type Assertion NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_head.
- NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_assertion description "[FGFR1 was expressed at high levels in the majority of tumours (69% of grade 3 or less, 74% of grade 4 and 70% of grade 5), while FGFR4 was strongly expressed in 83% of grade 5 cancers but in only 25% of grade 1-3 cancers (p < 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_provenance.
- NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_assertion evidence source_evidence_literature NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_provenance.
- NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_assertion SIO_000772 17607666 NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_provenance.
- NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_assertion wasDerivedFrom befree-20140225 NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_provenance.
- NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_assertion wasGeneratedBy ECO_0000203 NP593458.RAXPeYYkXjzx-sIXRuNKQjFOxaLQs7LWiGauHYtoThStw130_provenance.